Halton: Manufacturers must contribute to COVAX facility

"We are prioritising specific populations, not countries. This is the advantage of the global approach - fair and equitable access to an approved vaccine based on the most in-need populations groups, regardless of where they live," the chair of CEPI Jane Halton told BioPharmaDispatch. …